Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 1,772 | 1,300 | 2,777 | 2,908 | 3,185 |
| Cost of Goods | 2,276 | 2,240 | 2,920 | 2,580 | 1,970 |
| Gross Profit | -504 | -270 | -140 | 320 | 540 |
| Operating Expenses | 5,322 | 5,720 | 6,880 | 6,380 | 5,930 |
| Operating Income | -5,550 | -6,420 | -6,103 | -5,472 | -3,745 |
| Interest Expense | 50 | 0 | 0 | 0 | 0 |
| Other Income | 262 | 600 | -3,507 | 332 | -645 |
| Pre-tax Income | -5,338 | -5,820 | -9,610 | -5,140 | -4,390 |
| Net Income Continuous | -5,338 | -5,804 | -9,618 | -5,147 | -4,104 |
| Net Income Discontinuous | N/A | 0 | 0 | 0 | -288 |
| Net Income | $-5,338 | $-5,804 | $-9,618 | $-5,147 | $-4,392 |
| EPS Basic Total Ops | -0.16 | -0.20 | -0.38 | -0.21 | -0.18 |
| EPS Basic Continuous Ops | -0.16 | -0.20 | -0.38 | -0.21 | -0.17 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Total Ops | -0.16 | -0.20 | -0.38 | -0.21 | -0.18 |
| EPS Diluted Continuous Ops | -0.16 | -0.20 | -0.38 | -0.21 | -0.17 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EBITDA(a) | $-4,216 | $-7,090 | $-2,563 | $-3,922 | $-2,215 |